Login   |  Users Online: 609 Home Print this page Email this page Small font sizeDefault font sizeIncrease font size
Search Article 
Advanced search 
   Home | About us | Editorial board | Search | Ahead of print | Current issue | Archives | Submit article | Instructions | Subscribe | Contacts
Year : 2016  |  Volume : 37  |  Issue : 2  |  Page : 125-134

Adjuvant effect of Chakshushya Rasayana with beta-blocker eye drops in the management of progressive glaucomatous optic neuropathy: An open-label randomized controlled trial

1 Department of Shalakya, Institute of Post Graduate Teaching and Research In Ayurveda, Gujarat Ayurveda University, Jamnagar, Gujarat, India
2 Department of Shalakya, Chaudhary Brahm Prakash Ayurved Charak Sansthan, Guru Gobind Singh Indraprastha University, New Delhi, India
3 Department of Ophthalmology, Eye Care Hospital, Jamnagar, Gujarat, India

Correspondence Address:
Riju Agarwal
Department of Shalakya, Chaudhary Brahm Prakash Ayurved Charak Sansthan, Guru Gobind Singh Indraprastha University, New Delhi - 110 078
Login to access the Email id

Source of Support: None, Conflict of Interest: None

DOI: 10.4103/ayu.AYU_30_16

Rights and Permissions

Introduction: Primary open angle glaucoma is an insidious and chronic vision-threatening eye ailment due to neuro-retino-optic nerve degeneration, which may be due to the raised intraocular pressure (IOP) or due to independent factors. Management of glaucoma is mainly concentrated on lowering IOP that requires lifetime topical medication, different ocular medicaments for lowering of IOP, and surgical interventions, but it has its own limitations to control the progression of glaucomatous optic neuropathy (GON), and this is the reason behind the use of alternative neuroprotective adjuvants. Aim: To evaluate the neuroprotective effect of Ayurvedic line of management of progressive GON. Materials and Methods: Ingredients of trial drug Vara Fort powder (Chakshushya Rasayana) were procured from the Institute Pharmacy, except Swarnamakshika Bhasma, which was purchased from Dhootapapeshwar Pharmaceuticals. The patients fulfilling inclusion criteria, attending outpatient and inpatient departments, irrespective of their sex, race, religion, occupation, etc., were selected and divided into two groups with open-labeled randomization. In Group A, in addition to betaxolol (0.1*) or timolol (0.5*) (non-iobrim), Chakshushya Rasayana 6 g/day orally with Triphala Ghrita and honey along with Koshtha-Shuddhi(body-microchannel clearing treatment) protocol was tried. Nasya (oleation through nasal route) with Jeevantyadi Taila and Tarpana (eye satiation) with Go-Ghrita were also performed. In Group B (control), brimonidine (iobrim) 0.2* eye drop was used for 3 months. Results: Significant improvement was observed in subjective parameters in Group A such as blurred vision, frequent change of presbyopic glasses, and delayed dark adaptation. Conclusion: Chakshushya Rasayana, if administered in a systematic approach along with a modern topical betaxolol or timolol eye drops, has a definite role in improving the lost retinal sensitivity as much as up to 12 dB in 3 months duration.

Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)

 Article Access Statistics
    PDF Downloaded354    
    Comments [Add]    
    Cited by others 1    

Recommend this journal